Clinical Trial Update: The Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing whether tapering febuxostat dosing is safe and effective in gout patients who have had uric acid control for at least five year…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• Uloric (febuxostat)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Gout, Uric Acid | Phase 4 | Status: NOT_YET_RECRUITING